Article Information
History
- September 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Abdulafeez Akinloye1,
- Timothy Oyedeji1,
- Oluwasegun Eniayewu1,2,
- Babatunde Adeagbo1,
- Oluseye Bolaji1,
- Steve Rannard3,
- Andrew Owen4 and
- Adeniyi Olagunju4,*
- 1Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria
- 2Department of Pharmaceutical and Medicinal Chemistry, University of Ilorin, Ilorin, Nigeria
- 3Department of Chemistry, University of Liverpool, Liverpool, United Kingdom
- 4Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom
- ↵*Correspondence:
Dr Adeniyi Olagunju. Department of Pharmacology and Therapeutics, Sherrington Building, Ashton Street, University of Liverpool, Liverpool, L69 3GE, United Kingdom. Tel.: +44 (0)151 794 40418. Email: olagunju{at}liverpool.ac.uk.
Posted September 22, 2023.
Atazanavir/ritonavir increased tizoxanide exposure from oral nitazoxanide through pharmacokinetic interaction in healthy volunteers
